Latest Healthcare It News

Page 12 of 142
Micro-X Limited lifted revenues by 16% to $15.1 million for FY26 but posted a $9.9 million net loss, narrowing from the prior year. The company advanced key medical imaging milestones and initiated a strategic reset to sharpen commercial focus and reduce costs.
Ada Torres
Ada Torres
28 Aug 2026
Australian Foundation Investment Company (ASX:AFI) reported a $293.5 million profit for FY26, holding dividends steady despite portfolio returns lagging the market. Leadership transitioned as Alison Gibson took the helm following Mark Freeman’s retirement.
Claire Turing
Claire Turing
28 Aug 2026
Constellation Technologies (ASX:CT1) reported a 5% revenue decline to $1.71 million and a $458,246 net loss for FY26, weighed down by delayed hardware deployments and increased expenses. Recurring subscription revenue grew 22%, reflecting ongoing customer engagement.
Sophie Babbage
Sophie Babbage
28 Aug 2026
IMEXHS Limited has swung to a profit of $66,200 in 1H FY26, driven by a 17% revenue increase and a surge in underlying EBITDA to $1.27 million. The company’s AI-native radiology platform and Latin American partner expansion underpin growth amid ongoing sector liquidity challenges.
Ada Torres
Ada Torres
28 Aug 2026
Cobram Estate Olives (ASX:CBO) posted an 11.3% revenue increase to A$268.9 million in FY2026 but swung to a A$4.2 million net loss as costs surged and integration expenses weighed. The company declared a steady fully franked dividend of 4.5 cents per share.
Ada Torres
Ada Torres
28 Aug 2026
Resonance Health (ASX: RHT) reported a profitable turnaround in FY26, driven by growth across its imaging software, clinical trial services, and site network businesses.
Ada Torres
Ada Torres
28 Aug 2026
Austco Healthcare has delivered record FY26 financial results, driven by strong organic growth, acquisitions, and a growing software maintenance base, positioning the company for sustained earnings momentum.
Ada Torres
Ada Torres
27 Aug 2026
AI Private Opportunities Trust (ASX: AIX) has completed its first reporting period, raising $267 million and beginning deployment into high-profile private AI companies including ByteDance and Databricks.
Claire Turing
Claire Turing
27 Aug 2026
Clarity Pharmaceuticals reported a 67% increase in net loss to $107.2 million for FY26, driven by higher R&D spending, while advancing multiple Phase III trials and expanding manufacturing capacity ahead of commercialisation.
Ada Torres
Ada Torres
27 Aug 2026
Global Health Limited trimmed its FY26 net loss by 12.5% to A$758,220, driven by a 5.5% lift in recurring SaaS revenue and a 20% cut in employee costs aided by AI integration, though going concern risks remain.
Sophie Babbage
Sophie Babbage
27 Aug 2026
ImpediMed reported a 15% revenue increase to $14.6 million in FY26, broadened reimbursement coverage for its SOZO platform to 95% of the US population, and launched new applications in heart health and weight management.
Ada Torres
Ada Torres
27 Aug 2026
Stakk is on the cusp of completing its US$63 million acquisition of ParaScript, having secured shareholder approval and completed a A$27 million placement. The combined entity is poised to meet or exceed FY2027 revenue and EBITDA targets, reinforcing its digital trust platform strategy.
Sophie Babbage
Sophie Babbage
26 Aug 2026

Browse the archive

Full archive